• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

湿性黄斑变性注射8毫克阿柏西普后发生的视网膜血管阻塞性血管炎

Occlusive Retinal Vasculitis After Aflibercept 8mg Injection for Wet Macular Degeneration.

作者信息

Sisk Robert A

机构信息

Cincinnati Eye Institute, 9997 Carver Rd, Blue Ash, OH 45242, United States.

University of Cincinnati Medical Center, Department of Ophthalmology, 231 Albert Sabin Way, Cincinnati, OH 45267, United States.

出版信息

Retin Cases Brief Rep. 2025 Apr 2. doi: 10.1097/ICB.0000000000001757.

DOI:10.1097/ICB.0000000000001757
PMID:40184546
Abstract

PURPOSE

To describe a case of occlusive retinal vasculitis (ORV) following intravitreal aflibercept 8mg injection for wet macular degeneration.

METHODS

Retrospective, interventional case report.

RESULTS

A 72-year-old female presented with classic ORV 11 days after intravitreal aflibercept 8mg injection in her left eye for wet macular degeneration. Visual acuity (VA) declined from 20/30 to 20/400. Laboratory investigations including Gram stain and cultures of vitreous aspirate, studies for infectious and non-infectious uveitis and hypercoagulable state were all negative. Oral prednisone, sub-Tenon's triamcinolone acetonide (STTA), intravitreal dexamethasone and antibiotic injections, and topical steroids resulted in visual and anatomic improvement. ORV recurred when prednisone was tapered to 10mg/day and was controlled with additional STTA, oral solumedrol, and a 0.18mg fluocinolone acetonide implant. Subsequently exudation from wet macular degeneration recurred and responded to intravitreal faricimab with recovery to 20/30.

CONCLUSIONS

ORV is a rare complication of some intravitreal anti-VEGF medications and infectious causes of endophthalmitis. It can be managed with aggressive steroid treatment for an excellent visual outcome in some cases, although the disease may be chronic or recurrent.

摘要

目的

描述1例玻璃体腔注射8mg阿柏西普治疗湿性黄斑变性后发生的闭塞性视网膜血管炎(ORV)病例。

方法

回顾性干预性病例报告。

结果

一名72岁女性在左眼玻璃体腔注射8mg阿柏西普治疗湿性黄斑变性11天后出现典型的ORV。视力(VA)从20/30下降至20/400。包括玻璃体抽吸物革兰氏染色和培养、感染性和非感染性葡萄膜炎及高凝状态检查在内的实验室检查均为阴性。口服泼尼松、球周注射曲安奈德、玻璃体腔注射地塞米松和抗生素以及局部使用类固醇后,视力和解剖结构均有改善。当泼尼松减至10mg/天时,ORV复发,通过额外的球周注射曲安奈德、口服甲泼尼龙和植入0.18mg氟轻松醋酸酯得以控制。随后湿性黄斑变性渗出复发,玻璃体腔注射法西单抗后视力恢复至20/30。

结论

ORV是某些玻璃体腔抗VEGF药物和眼内炎感染原因的罕见并发症。在某些情况下,通过积极的类固醇治疗可取得良好的视力预后,尽管该病可能为慢性或复发性。

相似文献

1
Occlusive Retinal Vasculitis After Aflibercept 8mg Injection for Wet Macular Degeneration.湿性黄斑变性注射8毫克阿柏西普后发生的视网膜血管阻塞性血管炎
Retin Cases Brief Rep. 2025 Apr 2. doi: 10.1097/ICB.0000000000001757.
2
Intraocular inflammation after intravitreal injection of aflibercept 8 mg for treatment-refractory neovascular age-related macular degeneration: a case report.玻璃体内注射8毫克阿柏西普治疗难治性新生血管性年龄相关性黄斑变性后的眼内炎症:一例报告
BMC Ophthalmol. 2025 Jan 23;25(1):42. doi: 10.1186/s12886-024-03827-6.
3
Retinal arterial occlusive vasculitis after multiple intravitreal brolucizumab injections for diabetic macular edema.多次玻璃体内注射布罗珠单抗治疗糖尿病性黄斑水肿后发生的视网膜动脉闭塞性血管炎。
Am J Ophthalmol Case Rep. 2022 Dec 30;29:101788. doi: 10.1016/j.ajoc.2022.101788. eCollection 2023 Mar.
4
Bilateral occlusive retinal vasculitis secondary to intravitreal faricimab injection: a case report and review of literature.玻璃体内注射法西单抗继发双侧闭塞性视网膜血管炎:一例报告并文献复习
Eye Vis (Lond). 2024 Dec 3;11(1):48. doi: 10.1186/s40662-024-00416-y.
5
Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.玻璃体内注射与后Tenon囊下注射曲安奈德治疗弥漫性糖尿病性黄斑水肿的比较。
Ophthalmology. 2005 Sep;112(9):1557-63. doi: 10.1016/j.ophtha.2005.03.023.
6
Retinal vasculitis after intravitreal aflibercept 8 mg for neovascular age-related macular degeneration.玻璃体内注射阿柏西普 8mg 治疗新生血管性年龄相关性黄斑变性后视网膜血管炎。
Jpn J Ophthalmol. 2024 Sep;68(5):531-537. doi: 10.1007/s10384-024-01107-w. Epub 2024 Aug 20.
7
Intravitreal steroids for macular edema in diabetes.玻璃体内注射类固醇治疗糖尿病性黄斑水肿
Cochrane Database Syst Rev. 2020 Nov 17;11(11):CD005656. doi: 10.1002/14651858.CD005656.pub3.
8
Intraocular Inflammation, Safety Events, and Outcomes After Intravitreal Injection of Ranibizumab, Aflibercept, Brolucizumab, Abicipar Pegol, and Faricimab for nAMD.玻璃体内注射雷珠单抗、阿柏西普、布罗利珠单抗、阿比西帕聚乙二醇和法西单抗治疗新生血管性年龄相关性黄斑变性后的眼内炎症、安全事件及预后
J Vitreoretin Dis. 2025 Apr 21:24741264251332515. doi: 10.1177/24741264251332515.
9
Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration.玻璃体内注射布罗珠单抗后发生的视网膜动脉闭塞性血管炎。
Am J Ophthalmol Case Rep. 2020 Mar 31;18:100680. doi: 10.1016/j.ajoc.2020.100680. eCollection 2020 Jun.
10
Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER.Brolucizumab 相关炎症、视网膜血管炎和视网膜阻塞相关事件的风险:HAWK 和 HARRIER 的事后回顾。
Ophthalmology. 2021 Jul;128(7):1050-1059. doi: 10.1016/j.ophtha.2020.11.011. Epub 2020 Nov 15.

引用本文的文献

1
Initial Response After Switching to Aflibercept 8 mg for Neovascular Age-Related Macular Degeneration.转换为阿柏西普8毫克治疗新生血管性年龄相关性黄斑变性后的初始反应
J Clin Med. 2025 Jul 8;14(14):4824. doi: 10.3390/jcm14144824.